This newsletter focuses on the growing use of generative artificial intelligence (GenAI) in the healthcare and life sciences industries. It highlights the potential of GenAI to improve patient care, streamline workflows, and drive innovation. The newsletter features insights from Indy Sawhney, a strategic advisor at Amazon Web Services (AWS), who emphasizes the importance of responsible GenAI adoption. It also showcases a specific example of a GenAI tool called DrugGPT, which assists clinicians in medication prescribing, and provides advice for healthcare organizations to leverage this technology. The newsletter encourages readers to experiment with GenAI, collaborate with partners, and build responsible AI policies to navigate the evolving landscape of AI in healthcare.